Purpura, Thrombocytopenic, Idiopathic: all 521 studies
Page 3 of 6. Open to participants first (158), then studies with results posted, then the rest; newest registration first within each.
- Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving RomiplostimCompletedNCT01143038Phase 2Results posted
- An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)TerminatedNCT01129024Phase 2Results posted
- A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT01098487Phase 4Results posted
- A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia PurpuraCompletedNCT01071954Phase 3Results posted
- A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)TerminatedNCT01054443Phase 2Results posted
- Initial Treatment of Patients With Immune Thrombocytopenic PurpuraTerminatedNCT00991939Phase 3Results posted
- Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
- Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)CompletedNCT00907478Phase 4Results posted
- Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00902018Phase 2Results posted
- Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00828750Phase 3Results posted
- Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITPCompletedNCT00774202Phase 2/3Results posted
- A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00770562Phase 3Results posted
- Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)CompletedNCT00706342Phase 2Results posted
- Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic PurpuraCompletedNCT00699140Phase 3Results posted
- Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003CompletedNCT00625443Phase 2Results posted
- P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraCompletedNCT00603642Phase 3Results posted
- Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00540423Phase 3Results posted
- Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric SubjectsCompletedNCT00515203Phase 1/2Results posted
- IGIV Study for Chronic ITP Patients Ages 3-70CompletedNCT00511147Phase 3Results posted
- An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITPCompletedNCT00508820Phase 3Results posted
- A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00504075Phase 3Results posted
- A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.CompletedNCT00475423Phase 2Results posted
- Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00454857Results posted
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00441090Phase 2Results posted
- Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in AdultsCompletedNCT00426270Phase 3Results posted
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)CompletedNCT00424177Phase 2Results posted
- Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic PurpuraCompletedNCT00415532Phase 3Results posted
- Sirolimus for Autoimmune Disease of Blood CellsCompletedNCT00392951Phase 1/2Results posted
- RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagCompletedNCT00370331Phase 3Results posted
- EXTEND (Eltrombopag Extended Dosing Study)CompletedNCT00351468Phase 3Results posted
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITPCompletedNCT00220727Phase 2Results posted
- Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10CompletedNCT00168038Phase 3Results posted
- Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)CompletedNCT00117143Phase 1/2Results posted
- Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00116688Phase 3Results posted
- Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)CompletedNCT00111475Phase 2Results posted
- A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia PatientsCompletedNCT07805408
- Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune ThrombocytopeniaActive, not recruitingNCT07733037Phase 2
- Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed ConditionsActive, not recruitingNCT07675226Phase 1
- Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in JapanActive, not recruitingNCT07216079Phase 3
- Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in IraqCompletedNCT07150286Not applicable
- Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From IanalumabWithdrawnNCT07039422Phase 2
- A Clinical Study of YTS109 Cell in R/R Systemic Lupus ErythematosusTerminatedNCT06943937Phase 1
- Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)CompletedNCT06880081Phase 1
- Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune ThrombocytopeniaWithdrawnNCT06813157Not applicable
- Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)CompletedNCT06665308
- Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT06594146Phase 2
- A Study of PN20 in Healthy Adult VolunteersCompletedNCT06523088Phase 1
- Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune ThrombocytopeniaActive, not recruitingNCT06497036Phase 3
- Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With CancerCompletedNCT06444477
- Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in EuropeCompletedNCT06408324
- The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
- Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.CompletedNCT06288932Phase 3
- Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)CompletedNCT06287567Phase 2
- A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaActive, not recruitingNCT06199089Phase 2
- Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune ThrombocytopeniaWithdrawnNCT06176235Phase 2
- The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy SubjectsCompletedNCT06148389Phase 1
- Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR StudyCompletedNCT06071520
- A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of TherapiesActive, not recruitingNCT05885555Phase 2
- Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University HospitalStatus unknownNCT05835050Not applicable
- A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced ThrombocytopeniaTerminatedNCT05785819Phase 2
- An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)CompletedNCT05757570Phase 1/2
- A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaCompletedNCT05694767Phase 2
- Extension Study of Herombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaStatus unknownNCT05685420Phase 3
- Assesment of the Functional Activity of Platelets for the Differential Diagnosis of ThrombocytopathiesStatus unknownNCT05654766
- Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT05653349Phase 3
- A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsActive, not recruitingNCT05653219Phase 3
- IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownNCT05634824Phase 2
- Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune ThrombocytopeniaCompletedNCT05621330Phase 3
- Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITPCompletedNCT05613296
- " Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "Status unknownNCT05585944Not applicable
- A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP PtsCompletedNCT05583838Phase 4
- A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)CompletedNCT05566990Phase 3
- A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaActive, not recruitingNCT05562882Phase 2
- Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl CysteineCompletedNCT05551624Early Phase 1
- Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasWithdrawnNCT05509582Phase 2
- The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05494307Phase 2
- Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP PatientsCompletedNCT05492409Phase 3
- The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05471050Phase 2
- The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune ThrombocytopeniaStatus unknownNCT05468866Not applicable
- COVID-19 Vaccine and Development of Immune Thrombocytopenic PurpuraStatus unknownNCT05455983
- Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05446831Phase 2
- The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9CompletedNCT05438875Phase 3
- SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk PopulationsWithdrawnNCT05393999Phase 2
- Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)Status unknownNCT05371743
- The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
- The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in PregnancyStatus unknownNCT05333744Phase 2
- Herombopag + rhTPO in Severe Immune ThrombocytopeniaStatus unknownNCT05328804Phase 3
- Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune ThrombocytopeniaActive, not recruitingNCT05325593Phase 3
- Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP PatientsStatus unknownNCT05311930Phase 4
- Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05302024Phase 2
- The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05281068Phase 2
- A Study of Zanubrutinib in Patients With ITPCompletedNCT05279872Phase 2
- Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)CompletedNCT05263193
- A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune ThrombocytopeniaStatus unknownNCT05232149Phase 2
- Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITPCompletedNCT05220878Phase 3
- A Study of Orelabrutinib in Patients With ITPStatus unknownNCT05124028Phase 1/2
- Machine-learning Based Prediction Model in Primary Immune ThrombocytopeniaStatus unknownNCT05116423
- The Serum Lipid Profiles in ITP: a Retrospective StudyCompletedNCT05095896
- Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic PurpuraStatus unknownNCT05093257
- Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedNCT05070845Phase 2